SCHEMBL4550853

SCHEMBL4550853

COC(=O)c1ccc(Cl)cc1CCC1CCC(C(=O)OC)CN1C(=O)OC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
OPRK1 P41145 1/20 0.38
STS P08842 4/20 0.36
CTSL P07711 1/20 0.36
CTSB P07858 1/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
THRB P10828 1/20 0.35
USP30 Q70CQ3 1/20 0.35
KMT2A Q03164 2/20 0.35
MAPT P10636 2/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MAPK8 P45983 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15179604 0.84 EPHX2 (0.42) ALDH1A1OPRK1STSNR1H2NR1H3
SCHEMBL15169526 0.84 KDM4E (0.34) ALDH1A1OPRK1STSNR1H2NR1H3
SCHEMBL2729850 0.83 MMP13 (0.34) OPRK1STSNR1H2NR1H3USP30
SCHEMBL4550833 0.76 STS (0.38) ALDH1A1OPRK1STSCTSLCTSB
SCHEMBL15878226 0.74 SMN1; SMN2 (0.37) ALDH1A1OPRK1NR1H2NR1H3KMT2A
SCHEMBL15169247 0.73 ABL1 (0.35) ALDH1A1THRBKMT2AMEN1NPSR1
SCHEMBL15179603 0.73 ABL1 (0.40) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL21180886 0.72 ABL1 (0.48) ALDH1A1KMT2AMAPTMEN1LMNA
SCHEMBL27158644 0.71 SMN1; SMN2 (0.38) ALDH1A1OPRK1STSNR1H2NR1H3
SCHEMBL4550776 0.71 NR1H2 (0.40) ALDH1A1OPRK1NR1H2NR1H3USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130210804-A1 TRICYCLIC MGLUR5 RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. 2013-08-15 US disclosed
US-20130210804-A1 TRICYCLIC MGLUR5 RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. 2013-08-15 US disclosed
WO-2012061019-A2 TRICYCLIC MGLUR5 RECEPTOR MODULATORS MERCK SHARP & DOHME CORP. (US) 2012-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210804-A1 TRICYCLIC MGLUR5 RECEPTOR MODULATORS GRM5, GRM1, GRM2 ALDH1A1 4309/4885OPRK1 113/4885STS 3754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.